静脉注射(IV Solutions) 市场报告：2030 年趋势、预测与竞争分析

静脉注射（IV 溶液）的趋势和预测

预计到 2030 年，全球静脉注射市场将达到 233 亿美元，2024 年至 2030 年复合年增长率为 8.1%。这个市场的主要驱动因素是胃肠道疾病、神经系统疾病和癌症等疾病盛行率的上升，诊所、医院和专科护理单位等医疗设施的快速增长以及先进医疗技术的发展。全球静脉注射市场前景广阔，全肠外营养及週边肠外营养市场充满机会。

静脉注射输液市场洞察

Lucintel 预测，在预测期内，单给药胺基酸将继续成为最大的细分市场，因为它们为无法透过正常消化方式用餐或吸收足够的患者提供完整的营养支持。

由于主要企业较多、药品容易取得以及完善的医疗保健基础设施，预计欧洲在预测期内将出现最高的成长。

本报告回答了 11 个关键问题：

• Q.1. 细分市场中最有前途和高成长的机会是什么？
• Q.2.哪个细分市场将以更快的速度成长？为什么？
• Q.3.您认为哪些地区未来会出现更快的成长？为什么？
• Q.4. 影响市场动态的主要因素有哪些？市场的主要挑战和商业风险是什么？
• Q.5. 这个市场的商业风险和竞争威胁是什么？
• Q.6.这个市场有哪些新趋势？为什么？
• Q.7.市场客户需求有何改变？
• Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
• Q.9.这个市场的主要企业有哪些？主要企业采取哪些策略配合措施来发展业务？
• Q.10. 该市场上的竞争产品有哪些？由于材料或产品替代而导致市场占有率下降的威胁有多大？
• Q.11.过去五年发生了哪些併购事件，对产业产生了哪些影响？

目录

第一章执行摘要

第二章全球静脉注射市场：市场动态

• 简介、背景、分类
• 供应链
• 产业驱动因素与挑战

第三章 2018-2030年市场趋势及预测分析

• 宏观经济趋势（2018-2023）与预测（2024-2030）
• 全球静脉注射注射市场趋势（2018-2023）与预测（2024-2030）
• 按产品分類的全球静脉注射市场
  • 完全肠外营养
  • 週边肠外营养
• 按营养素分類的全球静脉注射市场
  • 碳水化合物
  • 维生素和矿物质
  • 单给药胺基酸
  • 肠外脂肪乳剂
  • 其他的

第四章 2018-2030年区域市场趋势及预测分析

• 全球静脉注射市场区域分布
• 北美静脉注射市场
• 欧洲静脉注射市场
• 亚太静脉注射市场
• 其他地区静脉注射市场

第五章竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 按产品分類的全球静脉注射市场成长机会
  • 全球静脉注射市场营养素的成长机会
  • 按地区分類的全球静脉注射市场成长机会
• 全球静脉注射市场新趋势
• 战略分析
  • 新产品开发
  • 扩大全球静脉注射市场产能
  • 全球静脉注射输液市场的合併、收购和合资企业
  • 认证和许可

第七章主要企业概况

• Pfizer
• Otsuka Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Vifor Pharma Management
• Grifols
• Henry Schein
• Soxa Formulations & Research
• B. Braun Melsungen
• Baxter International
• Fresenius Kabi

Intravenous Solution Trends and Forecast

The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets. The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030 with a CAGR of 8.1% from 2024 to 2030. The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.

A more than 150-page report is developed to help in your business decisions.

Intravenous Solution by Segment

The study includes a forecast for the global intravenous solution by product, nutrients, and region.

Intravenous Solution Market by Product [Shipment Analysis by Value from 2018 to 2030]:

• Total Parenteral Nutrition
• Peripheral Parenteral Nutrition

Intravenous Solution Market by Nutrients [Shipment Analysis by Value from 2018 to 2030]:

• Carbohydrates
• Vitamins & Minerals
• Single Dose Amino Acids
• Parenteral Lipid Emulsion
• Others

Intravenous Solution Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of Intravenous Solution Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies intravenous solution companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the intravenous solution companies profiled in this report include-

• Pfizer
• Otsuka Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Vifor Pharma Management
• Grifols
• Henry Schein
• Soxa Formulations & Research
• B. Braun Melsungen
• Baxter International
• Fresenius Kabi

Intravenous Solution Market Insights

Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.

Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.

Features of the Global Intravenous Solution Market

Market Size Estimates: Intravenous solution market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Intravenous solution market size by product, nutrients, and region in terms of value ($B).

Regional Analysis: Intravenous solution market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product, nutrients, and regions for the intravenous solution market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the intravenous solution market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q1. What is the intravenous solution market size?

Answer: The global intravenous solution market is expected to reach an estimated $23.3 billion by 2030.

Q2. What is the growth forecast for intravenous solution market?

Answer: The global intravenous solution market is expected to grow with a CAGR of 8.1% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the intravenous solution market?

Answer: The major drivers for this market are rising incidence of diseases like gastrointestinal disorders, neurological conditions, and cancer, swift growth of medical facilities, including clinics, hospitals, and specialized care units, and growth of advanced healthcare technology.

Q4. What are the major segments for intravenous solution market?

Answer: The future of the global intravenous solution market looks promising with opportunities in the total parenteral nutrition and peripheral parenteral nutrition markets.

Q5. Who are the key intravenous solution market companies?

Answer: Some of the key intravenous solution companies are as follows:

• Pfizer
• Otsuka Pharmaceutical
• Sichuan Kelun Pharmaceutical
• Vifor Pharma Management
• Grifols
• Henry Schein
• Soxa Formulations & Research
• B. Braun Melsungen
• Baxter International
• Fresenius Kabi

Q6. Which intravenous solution market segment will be the largest in future?

Answer: Lucintel forecasts that single dose amino acids will remain the largest segment over the forecast period because it provides complete nutritional support to patients who cannot eat or absorb enough food through regular digestive means.

Q7. In intravenous solution market, which region is expected to be the largest in next 5 years?

Answer: Europe is expected to witness highest growth over the forecast period because of strong presence of key players, ease of drug availability, and established healthcare infrastructure.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the intravenous solution market by product (total parenteral nutrition and peripheral parenteral nutrition), nutrients (carbohydrates, vitamins & minerals, single dose amino acids, parenteral lipid emulsion, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Intravenous Solution Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

• 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
• 3.2. Global Intravenous Solution Market Trends (2018-2023) and Forecast (2024-2030)
• 3.3: Global Intravenous Solution Market by Product
  • 3.3.1: Total Parenteral Nutrition
  • 3.3.2: Peripheral Parenteral Nutrition
• 3.4: Global Intravenous Solution Market by Nutrients
  • 3.4.1: Carbohydrates
  • 3.4.2: Vitamins & Minerals
  • 3.4.3: Single Dose Amino Acids
  • 3.4.4: Parenteral Lipid Emulsion
  • 3.4.5: Others

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

• 4.1: Global Intravenous Solution Market by Region
• 4.2: North American Intravenous Solution Market
  • 4.2.2: North American Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
• 4.3: European Intravenous Solution Market
  • 4.3.1: European Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
  • 4.3.2: European Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
• 4.4: APAC Intravenous Solution Market
  • 4.4.1: APAC Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
  • 4.4.2: APAC Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others
• 4.5: ROW Intravenous Solution Market
  • 4.5.1: ROW Intravenous Solution Market by Product: Total Parenteral Nutrition and Peripheral Parenteral Nutrition
  • 4.5.2: ROW Intravenous Solution Market by Nutrients: Carbohydrates, Vitamins & Minerals, Single Dose Amino Acids, Parenteral Lipid Emulsion, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Intravenous Solution Market by Product
  • 6.1.2: Growth Opportunities for the Global Intravenous Solution Market by Nutrients
  • 6.1.3: Growth Opportunities for the Global Intravenous Solution Market by Region
• 6.2: Emerging Trends in the Global Intravenous Solution Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Intravenous Solution Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Intravenous Solution Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Pfizer
• 7.2: Otsuka Pharmaceutical
• 7.3: Sichuan Kelun Pharmaceutical
• 7.4: Vifor Pharma Management
• 7.5: Grifols
• 7.6: Henry Schein
• 7.7: Soxa Formulations & Research
• 7.8: B. Braun Melsungen
• 7.9: Baxter International
• 7.10: Fresenius Kabi